Literature DB >> 15134860

Neuropeptide Y, ubiquitous and elusive.

Bibie M Chronwall1, Zofia Zukowska.   

Abstract

This paper reviews aspects of NPY research that were emerging in 1985, shortly after the isolation and characterization of the peptide. NPY had become known for its widespread distribution especially in the central and peripheral nervous systems, but also in the gastro-intestinal and respiratory tracts and in fibers innervating smooth muscle around blood vessels. Consistent with its distribution, it was determined that NPY is a potent vasoconstrictor, affects neuroendocrine systems and is involved in appetite regulation--areas of research still relevant today. Through advances in technology knowledge about NPY's role in these and newly discovered physiological functions has deepened considerably. Successful cloning of a series of NPY receptors has opened up new and complex research vistas. Lately, the creation of mice genetically modified for NPY as well as for several receptor subtypes has brought many puzzling observations--followed by questions yet to be answered.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15134860     DOI: 10.1016/j.peptides.2004.02.013

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  9 in total

Review 1.  Hungry for life: How the arcuate nucleus and neuropeptide Y may play a critical role in mediating the benefits of calorie restriction.

Authors:  Robin K Minor; Joy W Chang; Rafael de Cabo
Journal:  Mol Cell Endocrinol       Date:  2008-11-11       Impact factor: 4.102

2.  Neuropeptide Y receptors in carotid plaques of symptomatic and asymptomatic patients: effect of inflammatory cytokines.

Authors:  Divya Pankajakshan; Guanghong Jia; Iraklis Pipinos; Steve H Tyndall; Devendra K Agrawal
Journal:  Exp Mol Pathol       Date:  2011-02-23       Impact factor: 3.362

3.  Prenatal stress in the rat results in increased blood pressure responsiveness to stress and enhanced arterial reactivity to neuropeptide Y in adulthood.

Authors:  Natalia Igosheva; Paul D Taylor; Lucilla Poston; Vivette Glover
Journal:  J Physiol       Date:  2007-05-10       Impact factor: 5.182

Review 4.  The effects of NOS2 gene deletion on mice expressing mutated human AbetaPP.

Authors:  Carol A Colton; Donna M Wilcock; David A Wink; Judianne Davis; William E Van Nostrand; Michael P Vitek
Journal:  J Alzheimers Dis       Date:  2008-12       Impact factor: 4.472

5.  Plasticity of peptidergic innervation in healing rabbit medial collateral ligament.

Authors:  Paul T Salo; Jasmine A Beye; Ruth A Seerattan; Catherine A Leonard; Tyler J Ivie; Robert C Bray
Journal:  Can J Surg       Date:  2008-06       Impact factor: 2.089

6.  Chronic stress, combined with a high-fat/high-sugar diet, shifts sympathetic signaling toward neuropeptide Y and leads to obesity and the metabolic syndrome.

Authors:  Lydia E Kuo; Magdalena Czarnecka; Joanna B Kitlinska; Jason U Tilan; Richard Kvetnanský; Zofia Zukowska
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

7.  Long-Term Over-Expression of Neuropeptide Y in Hypothalamic Paraventricular Nucleus Contributes to Adipose Tissue Insulin Resistance Partly via the Y5 Receptor.

Authors:  Min Long; Jiyin Zhou; Dandan Li; Lu Zheng; Zihui Xu; Shiwen Zhou
Journal:  PLoS One       Date:  2015-05-18       Impact factor: 3.240

8.  Neuromodulatory connectivity defines the structure of a behavioral neural network.

Authors:  Feici Diao; Amicia D Elliott; Fengqiu Diao; Sarav Shah; Benjamin H White
Journal:  Elife       Date:  2017-11-22       Impact factor: 8.140

9.  Elevated Pentraxin 3 in Obese Adipose Tissue Promotes Adipogenic Differentiation by Activating Neuropeptide Y Signaling.

Authors:  Min-Kyung Shin; Bongkun Choi; Eun-Young Kim; Ji-Eun Park; Eui Seung Hwang; Hyang Ju Lee; Min Kyung Kim; Ji-Eun Kim; Seong Who Kim; Eun-Ju Chang
Journal:  Front Immunol       Date:  2018-07-30       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.